Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

PAF antagonist demonstrates antipruritic activity in patients with atopic dermatitis

Dec. 18, 1997

First U.S. trials of Zemaphyte to begin

Dec. 17, 1997

Once-daily tacalcitol vs. twice-daily calcipotriol for chronic plaque psoriasis

Dec. 17, 1997

Bard to distribute ProCyte's wound care products

Dec. 17, 1997

Gliatech's ADCON-L recommended for approval

Dec. 15, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

Preclinical profile of Novartis' dermatology candidate

Dec. 9, 1997

Promising results reported from pilot trial of Repel

Dec. 9, 1997

New melanogenesis inhibitor isolated from actinomycete

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...